Zyversa TherapeuticsZVSA
13F holders, Q3 2025 (September 30)1holders −5
1new positions
6sold out
$0.14avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Zyversa Therapeutics Inc. (ZVSA) in their 13F filings, down 5 from Q2 2025. 1 opened new positions and 6 sold out. The largest holder was Guerra Advisors Inc ($1).
- Company
- Zyversa Therapeutics Inc.
- CUSIP
- 98987D300
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1 |
| Exits | 6 | $45K |
All 13F filers, Q2 2025 → Q3 2025: 7 shares bought and 66,068 shares sold, net −66,061 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Guerra Advisors Inc | 0.00% | New | 7 | $1 |
"% of holder's portfolio" is ZVSA's weight in each manager's 13F, not the share of Zyversa Therapeutics Inc. the manager owns.